<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/C1B47689-5175-433F-8050-267F273C05DB" ns1:id="C1B47689-5175-433F-8050-267F273C05DB"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/C782FEA4-2B01-496A-AF35-3B002AA41C23" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/46116F61-1FC7-400D-8E23-F93DE38717EB" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/00ECAF89-BF44-4807-923A-61902B2B1C16" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/46116F61-1FC7-400D-8E23-F93DE38717EB" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2014-04-29T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/A865D4FD-EA05-498B-9861-8330E16FBDC5" ns1:rel="FUND" ns1:start="2013-04-30T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">131149</ns2:identifier></ns2:identifiers><ns2:title>Development of a in vitro living skin equivalent for testing anti-inflammatory substances</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Feasibility Studies</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>Epistem, a UK company with expertise in delivering dermatological testing services and ScandiDerma, a Norwegian company with expertise in developing new dermatological ingredients from biomass, aims to develop a new in vitro human living skin equivalent model for testing inflammatory responses. This is a novel method that will add to the field of dermatological testing as a whole and help create more activity in extracting high value compounds from biomass.</ns2:abstractText></ns2:project>